Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.20.4
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
Sep. 30, 2020
$ / shares
shares
Warrants outstanding 36
Warrant - Exercise Price 1,171,875.00 [Member]  
Warrants outstanding 1 [1]
Warrant exercise price | $ / shares $ 1,171,875.00
Warrant expiration date Apr. 26, 2021
Warrant - Exercise Price 195,312.50 [Member]  
Warrants outstanding 3 [2]
Warrant exercise price | $ / shares $ 195,312.50
Warrant expiration date Sep. 12, 2022
Warrant - Exercise Price 12,187.50 [Member]  
Warrants outstanding 32 [3]
Warrant exercise price | $ / shares $ 12,187.50
Warrant expiration date May 24, 2023
[1] Warrants issued in connection with the sale of convertible notes. The warrants were exercisable on the grant date (April 26, 2016) and remain exercisable until April 26, 2021.
[2] Warrants issued in connection with funding. The warrants were exercisable on the grant date (September 12, 2017) and remain exercisable until September 12, 2022.
[3] Warrants issued in connection with a Severance Agreement with Richard N. Azar II, the Company's former Chief Executive Officer. The warrants were exercisable on the grant date (May 25, 2018) and remain exercisable until May 24, 2023.